Effects of long-term low-dose mifepristone on reproductive function in women

Human Reproduction

Volumn 13, Issue 4, 1998, Pages 793-798

  Croxatto, H B ^a   Kovacs L ^b   Massai, R ^a   Resch, B A ^b   Fuentealba, B ^a   Salvatierra, A M ^a   Croxatto, H D ^a   Zalanyi S ^b   Viski, S ^b   Krenacs L ^b  

^a Instituto Chileno de Medicina Reproductiva   (Chile)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Antiprogestin; Endometrial contraception; Mifepristone; Ovarian cycle; Women

Indexed keywords

ANTIGESTAGEN; ESTRADIOL; LUTEINIZING HORMONE; MIFEPRISTONE; ORAL CONTRACEPTIVE AGENT; PROGESTERONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; ENDOMETRIUM; ENDOMETRIUM BIOPSY; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE STERILIZATION; HORMONE URINE LEVEL; HUMAN; HUMAN EXPERIMENT; LUTEAL PHASE; MENSTRUAL CYCLE; MENSTRUATION; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; OVARY CYCLE; OVARY FUNCTION; OVULATION; PROGESTERONE BLOOD LEVEL; REPRODUCTION; UTERINE CERVIX MUCUS;

EID: 2642645428     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/13.4.793     Document Type: Article

References (16)

1. Batista, M., Cartledge, T., Zellmer, A. et al. (1992) Delayed endometrial maturation induced by daily administration of the antiprogestin RU486: a potential new contraceptive strategy. Am. J. Obstet. Gynecol., 167, 60-65.
2. Cameron, ST., Critchley, H.O.D., Thong, K.J. et al. (1996) Effects of daily low dose mifepristone on endometrial maturation and proliferation. Hum. Reprod., 11, 2518-2526.
3. Croxatto, H., Salvatierra, A., Croxatto, H. et al. (1993) Effects of continuous treatment with low dose mifepristone throughout one menstrual cycle. Hum. Reprod., 8, 201-207.
4. Deraedt, R., Bonnat, C., Busigny, M. et al. (1985) Pharmacokinetics of RU 486. In Baulieu, E.E. and Segal, S.J. (eds), The Antiprogestin Steroid RU 486 and Human Fertility. Plenum Press, New York, NY, USA, pp. 103-122.
5. Gemzell-Danielsson, K., Swahn, M.L., Svalander, P. et al. (1993) Early luteal phase treatment with RU486 for fertility regulation. Hum. Reprod., 8, 870-873.
6. Gemzell-Danielsson, K., Westlund, P., Johannisson, E. et al. (1996) Effect of low weekly doses of mifepristone on ovarian function and endometrial development. Hum. Reprod., 11, 256-264.
7. Gemzell-Danielsson, K., Swahn, M. L., Westlund, P. et al. (1997) Effect of low daily doses of mifepristone on ovarian function and endometrial development. Hum. Reprod., 12, 124-131.
8. Gravanis, A., Schaison, G., George, M. et al. (1985) Endometrial and pituitary responses to the steroidal antiprogestin RU486 in postmenopausal women. J. Clin. Endocrinol. Metab., 60, 156-163.
9. Hosmer, D.W. and Lemeshow, S. (1989) Applied Logistic Regression. John Wiley & Sons, Inc., USA.
10. Kekkonen, R., Heikinheimo, O., Mandelin, E. et al. (1996) Pharmacokinetics of mifepristone after low oral doses. Contraception, 54, 229-234.
11. Ledger, W., Sweeting, V., Millier, H. et al. (1992) Inhibition of ovulation by low dose mifepristone (RU486). Hum. Reprod., 7, 945-950.
12. Noyes, R., Hertig, A. and Rock, J. (1950) Dating the endometrial biopsy. Fertil. Steril., 1, 3-25.
13. Scott, R.T., Jr (1994) Ultrasonographic evaluation of the endometrium during ovulation induction. In Jaffe, R., Pierson, R.A. and Abramowicz, J.S. (eds), Imaging in Infertility and Reproductive Endocrinology. J.B.Lippincott Co., Philadelphia, PA, USA, pp. 53-61.
14. Spitz, I., Croxatto, H. and Robbins, A. (1996) Antiprogestins: mechanism of action and contraceptive potential. Annu. Rev. Pharmacol. Toxicol., 36, 47-81.
15. Van Look, P. and von Hertzen, H. (1995) Clinical uses of antiprogestogens. Hum. Reprod. Update, 1, 19-34.
16. World Health Organization (1987) Laboratory Manual for the Examination of Human Semen and Semen-Cervical Mucus Interaction. 2nd edn, Cambridge University Press, Cambridge, UK.